MARC details
000 -LEADER |
fixed length control field |
04341cam a22005411i 4500 |
001 - CONTROL NUMBER |
control field |
0000032548 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20230921135341.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
fixed length control field |
m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr |n||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
211012s2021 sz m ob u000 0 eng d |
019 ## - |
-- |
1273980289 |
-- |
1275357132 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780128200162 : |
Terms of availability |
$182.00 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-030-76263-6 |
Source of number or code |
doi |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1274198590 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC270.8 |
Item number |
.M36 2021 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED062000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.99/406 |
Edition number |
23 |
245 00 - TITLE STATEMENT |
Title |
Micro and Nano Technologies : |
Remainder of title |
Nanomedicines for breast cancer theranostics. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
United Kingdom : |
Name of publisher, distributor, etc. |
Elsevier, |
Date of publication, distribution, etc. |
[2020. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
United Kingdom : |
Name of producer, publisher, distributor, manufacturer |
Elsevier , |
Date of production, publication, distribution, manufacture, or copyright notice |
[2020 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource : |
Other physical details |
illustrations (chiefly color) |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent. |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia. |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier. |
490 1# - SERIES STATEMENT |
Series statement |
Nanotechnology in the life sciences. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Preface -- Nanotheranostics -- Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics -- Nano-Oncology -- Cancer-Targeted Nanotheranostics -- Nanotheranostics -- Cancer Nano-Immunotherapy -- Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics -- Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy -- Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics -- Nanoerythrosome -- Role of Artificial Intelligence in Cancer Nanotheranostics -- Limitations of Current Cancer Nanotheranositcs -- Safety of nanobiomaterials for Cancer Nanotheranostics -- Index. |
506 ## - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Available to OhioLINK libraries. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cancer |
General subdivision |
Treatment |
-- |
Technological innovations. |
Authority record control number or standard number |
http://id.loc.gov/authorities/subjects/sh88000329. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cancer |
General subdivision |
Diagnosis. |
Authority record control number or standard number |
http://id.loc.gov/authorities/subjects/sh85019501. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Nanomedicine. |
Authority record control number or standard number |
http://id.loc.gov/authorities/subjects/sh2007008651. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Nanostructured materials. |
Authority record control number or standard number |
http://id.loc.gov/authorities/subjects/sh93000864. |
655 #4 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Saravanan, Muthupandian, |
Dates associated with a name |
1977- |
Authority record control number or standard number |
http://id.loc.gov/authorities/names/n2020180411, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Bauer Joanna, |
Relator term |
editor. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Bauer, |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
Ohio Library and Information Network. |
Authority record control number or standard number |
http://id.loc.gov/authorities/names/no95058981. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Qualifying information |
Original |
International Standard Book Number |
3030762629 |
-- |
9783030762629 |
Record control number |
(OCoLC)1246351031. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Nanotechnology in the life sciences. |
Authority record control number or standard number |
http://id.loc.gov/authorities/names/no2020041014. |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
OhioLINK |
Public note |
Connect to resource |
Uniform Resource Identifier |
<a href="https://rave.ohiolink.edu/ebooks/ebc2/9783030762636">https://rave.ohiolink.edu/ebooks/ebc2/9783030762636</a> |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
SpringerLink |
Public note |
Connect to resource |
Uniform Resource Identifier |
<a href="https://link.springer.com/10.1007/978-3-030-76263-6">https://link.springer.com/10.1007/978-3-030-76263-6</a> |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
SpringerLink |
Public note |
Connect to resource (off-campus) |
Uniform Resource Identifier |
<a href="http://proxy.ohiolink.edu:9099/login?url=https://link.springer.com/10.1007/978-3-030-76263-6">http://proxy.ohiolink.edu:9099/login?url=https://link.springer.com/10.1007/978-3-030-76263-6</a> |
908 ## - PUT COMMAND PARAMETER (RLIN) |
Put command parameter |
230208 |
913 ## - |
-- |
N |
989 #7 - |
-- |
20230822095114.0 |